Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
TRLS.L
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q2.22
N/A
-0.02
vs -0.01
Q4.22
N/A
-0.02
vs -0.02
Q2.23
N/A
-0.02
vs -0.02
Q4.23
N/A
-0.01
vs -0.02
Q2.24
N/A
-0.02
vs -0.02
Sales Growth
YoY
Current
Estimates
Q2.22
NA
10K vs NA
Q4.22
-68%
8K vs 25K
Q2.23
+40%
14K vs 10K
Q4.23
-37%
5K vs 8K
Q2.24
+257%
50K vs 14K
Return on Equity
QoQ
Q4.20
NA
NA
vs NA
Q2.21
-4%
-0.04
vs NA
Q4.21
-12%
-0.12
vs -0.04
Q2.22
-17%
-0.17
vs -0.12
Q4.22
-16%
-0.16
vs -0.17
Q2.23
-16%
-0.16
vs -0.16
Q4.23
-14%
-0.14
vs -0.16
Q2.24
-25%
-0.25
vs -0.14
Institutionnal Ownership
Quote Panel
Key Metrics
Relative Strength
TRLS.L
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
-65%2024-Revenue
100%2024-EBITDA
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Price Target
NaN(-100.00%)
Number of analyst
Last analyst upgrade/downgrade
No Data Available
Trellus Health plc provides digital chronic condition management solutions for employers and health plans. The company offers TrellusElevate, a proprietary HIPAA-compliant technology platform to coordinate and deliver personalized care remotely through telemedicine. Its platform provides patients with access to a care team, educational content resources, and remote monitoring capabilities for the treatment of inflammatory bowel diseases, which include the chronic incurable conditions of Crohn's Disease and ulcerative colitis. The company was founded in 2020 and is headquartered in White Plains, New York.
LSE
Unprofitable
Unprofitable
0.01Â ( 0.78%)
Pre-market NaN$0.00 (0.00%)
Relative Strenght
Volume Buzz
90%
Earning Acce
No
Dist 52w H.
88%Fundamentals
P/E Ratio
P/S Ratio
P/B Ratio
Debt/Equity
Net Margin
EPS
How TRLS.L compares to sector?